Efficacy and safety of zanubrutinib monotherapy for chronic lymphocytic leukemia/small lymphocytic lymphoma: A multicenter, real-world study in China

被引：0

作者：

Luo, Jing ^{[1
]}

Zhang, Jiaojiao ^{[1
]}

Liu, Ligen ^{[2
]}

Wei, Rong ^{[3
]}

Yao, Yonghua ^{[4
]}

Xu, Min ^{[5
]}

Shi, Jumei ^{[6
]}

Yang, Jianmin ^{[7
]}

Hou, Jian ^{[8
]}

Wang, Jin ^{[1
]}

Mi, Jian-Qing ^{[1
]}

机构：

[1] Shanghai Jiao Tong Univ, Ruijin Hosp, Shanghai Inst Hematol, Natl Res Ctr Translat Med Shanghai,Sch Med,State K, Shanghai 200025, Peoples R China

[2] Shanghai Jiao Tong Univ, Shanghai Tongren Hosp, Dept Hematol, Shanghai, Peoples R China

[3] Tongji Univ, Shanghai Peoples Hosp 10, Peoples Hosp 10, Dept Hematol, Shanghai, Peoples R China

[4] Univ Shanghai Sci & Technol, Shidong Hosp, Dept Hematol, Shanghai, Peoples R China

[5] Shanghai Univ Tradit Chinese Med, Longhua Hosp, Dept Hematol, Shanghai, Peoples R China

[6] Tongji Univ, Shanghai East Hosp, Shanghai Peoples Hosp 10, Peoples Hosp 10, Shanghai, Peoples R China

[7] Second Mil Med Univ, Changhai Hosp, Dept Hematol, Shanghai, Peoples R China

[8] Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Dept Hematol, Shanghai, Peoples R China

来源：

AMERICAN JOURNAL OF HEMATOLOGY | 2025年 / 100卷 / 01期

关键词：

D O I：

10.1002/ajh.27519

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：172 / 175

页数：4

共 50 条

[31] Treatment of relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma with the BTK inhibitor zanubrutinib: phase 2, single-arm, multicenter study
Xu, Wei
Yang, Shenmiao
Zhou, Keshu
Pan, Ling
Li, Zengjun
Zhou, Jianfeng
Gao, Sujun
Zhou, Daobin
Hu, Jianda
Feng, Ru
Huang, Haiwen
Ji, Meng
Guo, Haiyi
Huang, Jane
Novotny, William
Feng, Shibao
Li, Jianyong
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
[32] Real-world risk of bleeding events in patients with chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) treated with BTKi
Moslehi, Javid J.
Wahlstrom, Svea K.
Teschemaker, Anna
Mackey, Rachel H.
DeVincenzo, Diana
Carabuena, Leslie A.
Thompson, Samantha L.
Gordon, Brittaney
Rosenthal, Ning A.
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[33] Efficacy and Safety of Ibrutinib Use in Patients with Chronic Lymphocytic Leukemia in Real World Experiences: Results of a Prospective Multicenter Study
Tombak, Anil
Tanrikulu, Funda Pepedil
Durusoy, Salih Sertac
Gurkan, Emel
Kaya, Emin
Umit, Elif G.
Yavasoglu, Irfan
Mehtap, Ozgur
Deveci, Burak
Ozcan, Mehmet Ali
Terzi, Hatice
Okay, Mufide
Sayinalp, Nilgun
Yilmaz, Mehmet
Okan, Vahap
Kizikli, Alperen
Ozcan, Omer
Cetin, Guven
Demircioglu, Sinan
Aydogdu, Ismet
Saydam, Guray
Davulcu, Eren Arslan
Ilhan, Gul
Ucar, Mehmet Ali
Ozet, Gulsum
Akpinar, Seval
Turgut, Burhan
Berber, Ilhami
Kurtoglu, Erdal
Sonmez, Mehmet
Batur, Derya Selim
Yildirim, Rahsan
Ozkocaman, Vildan
Gunes, Ahmet Kursat
Sahip, Birsen
Ertop, Sehmus
Akay, Meltem
Basturk, Abdulkadir
Dogu, Mehmet Hilmi
Akdeniz, Aydan
Unal, Ali
Seyhanli, Ahmet
Ferhanoglu, Burhan
BLOOD, 2019, 134
[34] Real-World Efficacy of Venetoclax-Based Regimens in Patients with Chronic Lymphocytic Leukemia in Israel: A Multicenter Prospective Study
Herishanu, Yair
Goldschmidt, Neta
Itchaki, Gilad
Levi, Itai
Aviv, Ariel
Fineman, Riva
Dally, Najib
Tadmor, Tamar
Ruchlemer, Rosa
Abadi, Uri
Shvidel, Lev
Braester, Andrei
Cohen, Raanan
Frankel, Neta
Ofek, Keren
Berelovich, Jenia
Grunspan, Moshe
Benjamini, Ohad
BLOOD, 2021, 138 : 3727 - +
[35] Real-world management of small lymphocytic lymphoma as chronic lymphocytic leukaemia versus an indolent non-Hodgkin lymphoma
Puckrin, Robert
Owen, Carolyn
Stewart, Douglas
Peters, Anthea
BRITISH JOURNAL OF HAEMATOLOGY, 2023, 202 (02) : 445 - 448
[36] Real-World Characterization of Ibrutinib Therapy for Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL) Patients in British Columbia (BC)
Khelifi, Rania S.
Huang, Steven J. T.
Savage, Kerry J.
Villa, Diego
Scott, David W.
Ramadan, Khaled
Connors, Joseph M.
Sehn, Laurie H.
Toze, Cynthia L.
Gerrie, Alina S.
BLOOD, 2020, 136
[37] Clinical and economic burden of tumor lysis syndrome among patients with chronic lymphocytic leukemia/small lymphocytic lymphoma: A real-world US retrospective study
Rogers, Kerry A.
Lu, Xiaoxiao
Emond, Bruno
Cote-Sergent, Aurelie
Kinkead, Frederic
Lafeuille, Marie-Helene
Lefebvre, Patrick
Huang, Qing
JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2022, 28 (09): : 1033 - 1045
[38] Real-world effectiveness and safety of ibrutinib in patients with chronic lymphocytic leukemia in Japan: the Orbit study
Muta, Tsuyoshi
Masamoto, Yosuke
Yamamoto, Go
Kurahashi, Shingo
Kameoka, Yoshihiro
Ota, Shuichi
Matsuki, Eri
Ozeki, Kazutaka
Toyama, Takanori
Takahashi, Naoki
Kumode, Takahiro
Aotsuka, Nobuyuki
Yoshimura, Takuro
Tamura, Hideto
Omi, Ai
Shibayama, Kazuhiro
Watanabe, Aki
Isobe, Yasushi
Kojima, Kensuke
Takizawa, Jun
Nagai, Hirokazu
Suzumiya, Junji
Aoki, Sadao
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2024, : 161 - 173
[39] Indirect comparisons of efficacy of zanubrutinib versus orelabrutinib in patients with relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma or relapsed or refractory mantle cell lymphoma
Song, Yuqin
Zhou, Keshu
Yang, Shenmiao
Hu, Jianda
Zou, Dehui
Gao, Sujun
Pan, Ling
Wang, Tingyu
Yang, Haiyan
Zhang, Huilai
Zhou, Daobin
Ji, Jie
Xu, Wei
Feng, Ru
Jin, Jie
Lv, Fangfang
Huang, Haiwen
Fan, Xiaosi
Xu, Sheng
Zhu, Jun
INVESTIGATIONAL NEW DRUGS, 2023, 41 (04) : 606 - 616
[40] Indirect comparisons of efficacy of zanubrutinib versus orelabrutinib in patients with relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma or relapsed or refractory mantle cell lymphoma
Yuqin Song
Keshu Zhou
Shenmiao Yang
Jianda Hu
Dehui Zou
Sujun Gao
Ling Pan
Tingyu Wang
Haiyan Yang
Huilai Zhang
Daobin Zhou
Jie Ji
Wei Xu
Ru Feng
Jie Jin
Fangfang Lv
Haiwen Huang
Xiaosi Fan
Sheng Xu
Jun Zhu
Investigational New Drugs, 2023, 41 : 606 - 616

← 1 2 3 4 5 →